P3 Health Partners Inc. (PIII) EPS (Basic) (2021 - 2026)
P3 Health Partners' (PIII) quarterly EPS (Basic) came in at -$50.69 in Q4 2025, down 13.97% YoY from -$58.92 in Q4 2024, and down 138.5% on a QoQ basis from -$21.25 in Q3 2025.
P3 Health Partners Inc. (PIII) EPS (Basic) (2021 - 2026) Analysis & Trends
P3 Health Partners (PIII) has 5 years of EPS (Basic) data on file, last reported at -$50.69 in Q4 2025.
- Quarterly EPS (Basic) fell 13.97% year-over-year to -$50.69 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$98.83 (up 7.54% YoY) and the FY2025 annual result came in at -$98.83, up 7.54% from the prior year.
- EPS (Basic) declined to -$50.69 in Q4 2025, from -$21.25 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$10.53 in Q2 2024 to a low of -$639822.1 in Q4 2022.
- A 5-year average of -$32075.8 and a median of -$38.64 in 2021 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) sank 2083.2% — and 2023, when it surged 99.99%.
- Tracing PIII's EPS (Basic) over 5 years: stood at -$41.39 in 2021, then slumped by 1545678.21% to -$639822.1 in 2022, then surged by 99.99% to -$36.41 in 2023, then declined by 22.15% to -$44.48 in 2024, then dropped by 13.97% to -$50.69 in 2025.
- The last three EPS (Basic) figures came in at -$50.69 (Q4 2025), -$21.25 (Q3 2025), and -$13.37 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.63 |
| Dec 31, 2025 | -50.69 |
| Sep 30, 2025 | -21.25 |
| Jun 30, 2025 | -13.37 |
| Mar 31, 2025 | -13.57 |
| Dec 31, 2024 | -44.48 |
| Sep 30, 2024 | -31.77 |
| Jun 30, 2024 | -10.53 |
| Mar 31, 2024 | -20.86 |
| Dec 31, 2023 | -36.41 |
| Sep 30, 2023 | -16.33 |
| Jun 30, 2023 | -12.83 |
| Mar 31, 2023 | -63.07 |
| Dec 31, 2022 | -639,822.12 |
| Sep 30, 2022 | -78.56 |
| Jun 30, 2022 | -1,086.01 |
| Mar 31, 2022 | -12.72 |
| Dec 2, 2021 | -41.39 |
| Sep 30, 2021 | -49.38 |
| Jun 30, 2021 | -49.74 |